Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Discovery of Pyrazole-Containing RGD Mimics with Anti-Fibrotic Efficacy in the Unilateral Ureteral Obstruction Mouse Model.
Journal: Journal of medicinal chemistry
Published: February 05, 2026
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation.
Journal: Journal of medicinal chemistry
Published: August 31, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists.
Journal: ACS medicinal chemistry letters
Published: February 22, 2022
Correction to Polyelemental Nanoparticles as Catalysts for a Li-O2 Battery.
Journal: ACS nano
Published: April 14, 2021
Polyelemental Nanoparticles as Catalysts for a Li-O2 Battery.
Journal: ACS nano
Published: March 11, 2021
Structural characterization and developability assessment of sustained release hydrogels for rapid implementation during preclinical studies.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: July 25, 2020
Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists.
Journal: Bioorganic & medicinal chemistry letters
Published: May 28, 2020
One-Step Diastereoselective Pyrrolidine Synthesis Using a Sulfinamide Annulating Reagent.
Journal: Organic letters
Published: October 25, 2019
Fast understanding of phases and phase separation in liquid crystal drug delivery systems using deuterium solid-state NMR.
Journal: Solid state nuclear magnetic resonance
Published: October 08, 2019
Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors.
Journal: ACS medicinal chemistry letters
Published: January 28, 2019
TCFH-NMI: Direct Access to N-Acyl Imidazoliums for Challenging Amide Bond Formations.
Journal: Organic letters
Published: June 30, 2018
BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder.
Journal: ACS medicinal chemistry letters
Published: February 15, 2018
Last Updated: 09/26/2026